TEST CATALOG ORDERING & RESULTS SPECIMEN HANDLING CUSTOMER SERVICE EDUCATION & INSIGHTS
Test Catalog

Test ID: MAS1    
Autoimmune Myelopathy Evaluation, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Evaluating patients with suspected autoimmune myelopathy, myelitis, paraneoplastic myelopathy using serum specimens

Profile Information A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and includes reporting names and individual availability.

Test IDReporting NameAvailable SeparatelyAlways Performed
MSI1Autoimmune Myelopathy Interp, SNoYes
AMPHSAmphiphysin Ab, SNoYes
AGN1SAnti-Glial Nuclear Ab, Type 1NoYes
ANN1SAnti-Neuronal Nuclear Ab, Type 1NoYes
ANN2SAnti-Neuronal Nuclear Ab, Type 2NoYes
ANN3SAnti-Neuronal Nuclear Ab, Type 3NoYes
CRMWSCRMP-5-IgG Western Blot, SYesYes
CRMSCRMP-5-IgG, SNoYes
DPPISDPPX Ab IFA, SNoYes
GD65SGAD65 Ab Assay, SYesYes
GFAISGFAP IFA, SNoYes
GL1ISmGluR1 Ab IFA, SNoYes
MOGFSMOG FACS, SYesYes
NIFISNIF IFA, SNoYes
NMOFSNMO/AQP4 FACS, SYesYes
CCNN-Type Calcium Channel AbNoYes
CCPQP/Q-Type Calcium Channel AbNoYes
PCABPPurkinje Cell Cytoplasmic Ab Type 1NoYes
PCAB2Purkinje Cell Cytoplasmic Ab Type 2NoYes
PCATRPurkinje Cell Cytoplasmic Ab Type TrNoYes

Reflex Tests Lists tests that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial tests.

Test IDReporting NameAvailable SeparatelyAlways Performed
AGNBSAGNA-1 Immunoblot, SNoNo
AINCSAlpha Internexin CBA, SNoNo
AMPCSAMPA-R Ab CBA, SNoNo
AMPISAMPA-R Ab IF Titer Assay, SNoNo
AMIBSAmphiphysin Immunoblot, SNoNo
AN1BSANNA-1 Immunoblot, SNoNo
AN2BSANNA-2 Immunoblot, SNoNo
DPPCSDPPX Ab CBA, SNoNo
DPPTSDPPX Ab IFA Titer, SNoNo
GABCSGABA-B-R Ab CBA, SNoNo
GABISGABA-B-R Ab IF Titer Assay, SNoNo
GFACSGFAP CBA, SNoNo
GFATSGFAP IFA Titer, SNoNo
GL1CSmGluR1 Ab CBA, SNoNo
GL1TSmGluR1 Ab IFA Titer, SNoNo
MOGTSMOG FACS Titer, SNoNo
NFHCSNIF Heavy Chain CBA, SNoNo
NIFTSNIF IFA Titer, SNoNo
NFLCSNIF Light Chain CBA, SNoNo
NMDCSNMDA-R Ab CBA, SNoNo
NMDISNMDA-R Ab IF Titer Assay, SNoNo
NMOTSNMO/AQP4 FACS Titer, SNoNo
PC1BSPCA-1 Immunoblot, SNoNo
PCTBSPCA-Tr Immunoblot, SNoNo

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

If indirect immunofluorescence assay (IFA) patterns suggest AGNA-1 antibody, then AGNA-1 Immunoblot is performed at an additional charge.

 

If IFA patterns suggest amphiphysin antibody, then amphiphysin immunoblot is performed at an additional charge.

 

If IFA patterns suggest ANNA-1 antibody, then ANNA-1 immunoblot is performed at an additional charge.

 

If IFA patterns suggest ANNA-2 antibody, then ANNA-2 immunoblot is performed at an additional charge.

 

If IFA patterns suggest PCA-1 antibody, then PCA-1 immunoblot is performed at an additional charge.

 

If IFA patterns suggest PCA-Tr antibody, then PCA-Tr immunoblot is performed at an additional charge.

 

If IFA pattern suggests NMDA-receptor antibody, then NMDA- receptor R antibody cell-binding assay (CBA) and NMDA- receptor R titer are performed at an additional charge.

 

If IFA pattern suggests AMPA- receptor antibody, then AMPA- receptor antibody CBA and AMPA- receptor titer are performed at an additional charge.

 

If IFA pattern suggests GABA-B- receptor antibody, then GABA-B- receptor antibody CBA and GABA-B- receptor titer are performed at an additional charge.

 

If IFA pattern suggests DPPX antibody, then DPPX antibody CBA and DPPX IFA titer are performed at an additional charge.

 

If IFA pattern suggests mGluR1 antibody, then mGluR1antibody CBA and mGluR1 IFA titer are performed at an additional charge.

 

If IFA pattern suggests GFAP antibody, then GFAP antibody CBA and GFAP IFA titer are performed at an additional charge.

 

If NMO/AQP4-IgG FACS screen assay requires further investigation, then NMO/AQP4-IgG FACS titration assay is performed at an additional charge.

 

If MOG FACS screen assay requires further investigation, then MOG FACS titration assay is performed at an additional charge.

 

If IFA pattern suggests NIF antibody, then alpha internexin CBA, NIF heavy chain CBA, NIF light chain CBA, and NIF titer are performed at an additional charge.

 

See Autoimmune Myelopathy Evaluation Algorithm-Serum in Special Instructions.

Special Instructions Library of PDFs including pertinent information and forms related to the test

Method Name A short description of the method used to perform the test

AGN1S, AMPHS, AMPIS, ANN1S, ANN2S, ANN3S, CRMS, DPPIS, DPPTS, GABIS, GFAIS, GFATS, GL1IS, GL1TS, NIFIS, NIFTS, NMDIS, PCAB2, PCABP, PCATR: Indirect Immunofluorescence Assay (IFA)

 

CCN, CCPQ, GD65S: Radioimmunoassay (RIA)

 

CRMWS: Western Blot (WB)

AGNBS, AMIBS, AN1BS, AN2BS, PC1BS, PCTBS: Immunoblot (IB)

 

MOGFS, MOGTS, NMOFS, NMOTS: Flow Cytometry (FACS)

 

AINCS, AMPCS, DPPCS, GABCS, GFACS, GL1CS, NFHCS, NFLCS, NMDCS: Cell-Binding Assay (CBA)

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

Autoimmune Myelopathy Eval, S

Aliases Lists additional common names for a test, as an aid in searching

Paraneoplastic myelopathy
Neuromyelitis optica
Anti-MOG
Anti-GFAP